News Snapshot:
Naver By Riyaz ul Khaliq ANKARA (AA) – A potential COVID-19 vaccine jointly produced by Taiwan and the US has entered its final stage, said Taiwan's Food and Drug Administration (FDA). The vaccine — MVC-COV1901 — is being jointly developed by Taiwan's Medigen Vaccine Biologics Corp. and the US National Institutes of Health, and was granted approval for human trials, daily Taiwan News reported on Thursday. It is the third such potential vaccine being produced in the island nation. Adimmune Corp. and United Biomedical Inc. are also working on potential COVID-19 vaccines. The vaccine had received conditional approval for clinical...
